Baxter International Inc
DUS:BTL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
B
|
Baxter International Inc
DUS:BTL
|
US |
|
Codan Ltd
OTC:CODLY
|
AU |
Intrinsic Value
The intrinsic value of 
Baxter International Inc (BTL) under the Base Case is 85.38 EUR per share.
Compared with the current market price of 67.08 EUR, the stock appears
Undervalued by 21% .
The intrinsic value is the average of valuations using the DCF method and multiples.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What Baxter International Does
Baxter International makes medical products that hospitals and other care providers use to treat patients every day. Its lineup includes IV fluids, infusion pumps, drug-delivery systems, nutrition therapies, and disposable supplies that help doctors and nurses give medicines, fluids, and nutrition safely and consistently.
- Headquarters
- United States of America US
- Employees
- 37 500
- IPO date
- May 15, 1961
Baxter International has a narrow economic moat
Replacing equipment tied into hospital records and daily care routines takes money, staff training and careful testing. This gives Baxter a lasting foothold where hospitals already use its connected pumps, beds and communication systems, rather than protecting every product it sells.
Read the full moat analysis
Revenue & Expenses Breakdown
Baxter International Inc
Earnings Waterfall
Baxter International Inc
The intrinsic value for Baxter International Inc (BTL) under the Base Case is 85.38 EUR.
Compared with the current market price of 67.08 EUR, the stock appears Undervalued by 21% .